Bristol-Myers Squibb Company (BMV:BMY)

Mexico flag Mexico · Delayed Price · Currency is MXN
960.00
+20.00 (2.13%)
Last updated: Jun 9, 2025
26.32%
Market Cap 1.90T
Revenue (ttm) 973.63B
Net Income (ttm) 110.76B
Shares Out n/a
EPS (ttm) 54.58
PE Ratio 17.15
Forward PE 7.48
Dividend 47.72 (4.97%)
Ex-Dividend Date Apr 4, 2025
Volume n/a
Average Volume 194
Open 960.00
Previous Close 940.00
Day's Range 960.00 - 960.00
52-Week Range 712.66 - 1,261.00
Beta 0.39
RSI 57.49
Earnings Date Jul 31, 2025

About BMV:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.